Mural Oncology Management
Management criteria checks 0/4
Mural Oncology's CEO is Caroline Loew, appointed in Nov 2023, has a tenure of 1.17 years. total yearly compensation is $2.52M, comprised of 2.9% salary and 97.1% bonuses, including company stock and options. directly owns 1.39% of the company’s shares, worth $765.16K. The average tenure of the management team and the board of directors is 1.2 years and 1.2 years respectively.
Key information
Caroline Loew
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 2.9% |
| CEO tenure | 1.2yrs |
| CEO ownership | 1.4% |
| Management average tenure | 1.2yrs |
| Board average tenure | 1.2yrs |
Recent management updates
Recent updates
Here's Why We're Watching Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Nov 26
Here's Why We're A Bit Worried About Mural Oncology's (NASDAQ:MURA) Cash Burn Situation
Jul 17We're Keeping An Eye On Mural Oncology's (NASDAQ:MURA) Cash Burn Rate
Mar 28Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value
Mar 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$154m |
| Jun 30 2024 | n/a | n/a | -US$173m |
| Mar 31 2024 | n/a | n/a | -US$192m |
| Dec 31 2023 | US$3m | US$74k | -US$207m |
Compensation vs Market: Caroline's total compensation ($USD2.52M) is above average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Insufficient data to compare Caroline's compensation with company performance.
CEO
Caroline Loew (53 yo)
1.2yrs
Tenure
US$2,522,917
Compensation
Ms. Caroline J. Loew, PhD., serves as CEO & Director at Mural Oncology plc since November 15, 2023 and also serves as a President. She served as President, Chief Executive Officer and Director of Glympse B...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | US$2.52m | 1.39% $ 765.2k | |
| CFO, Principal Financial Officer & Principal Accounting Officer | 1.2yrs | US$1.18m | 0.072% $ 39.6k | |
| Chief Medical Officer | 1.2yrs | US$1.21m | 0.077% $ 42.5k | |
| Chief Legal Officer | 1.2yrs | no data | 0.24% $ 133.0k | |
| Head of Human Resources & VP of Human Resources | no data | no data | no data |
1.2yrs
Average Tenure
52yo
Average Age
Experienced Management: MURA's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.2yrs | US$2.52m | 1.39% $ 765.2k | |
| Independent Chairman of the Board | 1.2yrs | US$65.97k | 0% $ 0 | |
| Independent Director | 1.2yrs | US$58.63k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 1.2yrs | US$51.79k | 0% $ 0 | |
| Director | less than a year | no data | no data |
1.2yrs
Average Tenure
56yo
Average Age
Experienced Board: MURA's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 02:04 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Mural Oncology plc is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andres Maldonado | H.C. Wainwright & Co. |
| Judah Frommer | Morgan Stanley |
| Laura Prendergast | Raymond James & Associates |